Tag Archives | Research and Development

Congressional Republicans are on the verge of passing their disastrous tax bill. Don’t believe for a minute that it will ‘trickle down’ to workers

By Sen. Cory Booker (originally published by Medium) - President Trump and Congressional Republicans are now on the verge of passing a disastrous tax plan into law that will raise taxes for millions of low-and middle-income workers and threaten critical programs that make our economy fairer and stronger — all to give a tax break to large corporations […]

Continue Reading 0

It looks like Trump’s people have fallen for big pharma’s nonsense, hook, line, and sinker

By Linette Lopez (originally published by Business Insider) - The Trump administration has yet to take any meaningful action on lowering the price of drugs in America, and we may have just found out why. In a CNBC interview on Friday, Commerce Secretary Wilbur Ross demonstrated that he had fallen for big pharma’s nonsense hook, line, and sinker… [Cross-posted from […]

Continue Reading 0

Jamie Dimon needs to stop gaslighting America

By Linette Lopez (originally published by Business Insider) - For quarter after quarter — just as he did on Tuesday — he has joined with other CEOs of the Business Roundtable (which is exactly what it sounds like) and insisted that the US tax system is the single biggest disadvantage they face in the global market… [Cross-posted […]

Continue Reading 0

Is capitalism killing America?

By Theodore Kinni (originally published by Insights by Stanford Business) - On August 2, 2017, the Dow Jones Industrial Average hit a record-breaking 22,000 — its fourth 1,000-point advance in less than a year. That same day, I read the first sentence in Peter Georgescu new book, Capitalists Arise! End Economic Inequality, Grow the Middle Class, Heal the Nation (Berrett-Koehler, 2017): […]

Continue Reading 0

Les pharmas dépensent autant pour leurs actionnaires que pour la recherché

By Marie Maurisse (originally published by Le Temps) - Entre 2006 et 2015, Novartis a versé presque autant d’argent à ses actionnaires qu’elle n’en a investi en recherche et développement (R&D). Une étude récente pointe les dérives d’une telle évolution… [Cross-posted from Le Temps publication of August 18, 2017 at https://www.letemps.ch/economie/pharmas-depensent-autant-leurs-actionnaires-recherche?utm_campaign=article&utm_medium=share&utm_source=facebook]

Continue Reading 0

R and D

By Dan Crawford (originally published by Angry Bear) – Price gouging in the US pharmaceutical drug industry goes back more than three decades. In 1985 US Representative Henry Waxman, chair of the House Subcommittee on Health and the Environment, accused the pharmaceutical industry of “gouging the American public” with “outrageous” price increases, driven by “greed on […]

Continue Reading 0

Inside the defense buyback bonanza

Austin Wright (originally published by Politico) - Our colleague Austin Wright has a look at the industry’s controversial stock maneuver: “Defense stocks are soaring despite a decline in military spending because of tactics that are at odds with the interests of the Pentagon and drawing fire from some members of Congress. The nation’s five top defense firms […]

Continue Reading 0

developed by bodhiWeb